Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, the developing R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare.
According to a new report published by Allied Market Research, titled, “Alopecia Treatment Market by Drug Type, Indication, and End User: Global Opportunity Analysis and Industry Forecast, 2019–2026,” the global alopecia treatment market size was valued at $2,736 million in 2018, and is projected to reach $3,935 million by 2026, growing at a CAGR of 4.6% from 2019 to 2026.
Download PDF Sample Report: https://www.alliedmarketresearch.com/request-sample/6310
The alopecia treatment market is expected to experience significant growth during the forecast period, owing to surge in geriatric population; rise in prevalence of alopecia conditions such as androgenic alopecia, alopecia areata, alopecia totalis, and others; and increase in prevalence of chemotherapy induced alopecia. In addition, high level of stress, hormonal imbalance, increase in consumption of alcohol & tobacco, and change in food habits further drives the market growth.
Key Findings of the Study:
- Based on drug type, the minoxidil segment held more than 44.35% share in the global market in 2018.
- By indication, the androgenic alopecia segment accounted for the largest market share in 2018, and is expected to remain dominant throughout the forecast period.
- Based on distribution channel, the drug stores & retail pharmacies segment held 58.27% share in the global market in 2018.
- Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 5.9% during the forecast period.
Key Market Segments
- BY DISTRIBUTION CHANNEL
- Hospitals Pharmacies
- Drug Stores & Retail Pharmacies
- Online Pharmacies
- By Indication
- Androgenic Alopecia
- Alopecia Areata
- Alopecia Totalis
- Others
- By Drug Type
- Minoxidil
- Finasteride
- Other Drug Types
The key players profiled in this report include Capillus, LLC, Cipla Inc., Daiichi Sankyo Company, Limited, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Transitions Hair, Vitabiotics Ltd., and Vita-Cos-Med Klett-Loch GmbH.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/6310
External Defibrillators Market
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.